NADPH:quinone reductase

NADPH:quinone reductase is an enzyme that plays a crucial role in the antioxidant defense system of cells, protecting them from oxidative damage. This enzyme, also known as NQO1 (NAD(P)H dehydrogenase, quinone 1), is involved in the reduction of quinones to hydroquinones. This reaction is significant because it bypasses the formation of semiquinone radicals and reactive oxygen species (ROS), which can be harmful to cellular components such as DNA, proteins, and lipids.

Function

NADPH:quinone reductase catalyzes the two-electron reduction of quinones to hydroquinones. This reaction utilizes NADPH as an electron donor and plays a key role in cellular defense against oxidative stress. The reduced hydroquinones can then be conjugated to water-soluble compounds and excreted from the body, thereby detoxifying potentially harmful quinones and preventing their participation in redox cycling.

Mechanism

The enzyme operates through a ping-pong mechanism, where the enzyme first binds NADPH and reduces a FAD cofactor. Subsequently, the reduced FADH2 transfers electrons to the quinone substrate, converting it into a hydroquinone. This mechanism ensures the efficient reduction of quinones and minimizes the production of ROS.

Clinical Significance

NADPH:quinone reductase has been implicated in the protection against cancer, as it detoxifies carcinogens and quinones that can lead to tumor development. Additionally, its activity is increased in some cancer cells, providing resistance against certain chemotherapy drugs. Therefore, NQO1 is considered a potential target for cancer therapy, aiming to modulate its activity to enhance the effectiveness of chemotherapy.

Genetic Aspects

The gene encoding NQO1, also referred to as NQO1, is subject to polymorphisms that can affect the enzyme's activity. Certain polymorphisms lead to a reduction or loss of enzyme activity, which may increase the risk of cancer development due to decreased detoxification capacity.

Pharmacology

Inhibitors and activators of NADPH:quinone reductase are of interest for their potential therapeutic applications. Activators can enhance the detoxification process, offering protection against oxidative damage and carcinogenesis. Conversely, inhibitors may be used to sensitize cancer cells to chemotherapy by reducing their antioxidant defenses.

Conclusion

NADPH:quinone reductase is a vital enzyme in the cellular defense mechanism against oxidative stress and carcinogenesis. Its role in detoxifying quinones and its potential as a therapeutic target in cancer treatment highlight the importance of understanding its function, mechanism, and genetic regulation.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian